John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$297M |
| 2 |
Bank of America
BAC
|
+$249M |
| 3 |
Oracle
ORCL
|
+$247M |
| 4 |
Microsoft
MSFT
|
+$246M |
| 5 |
Snap
SNAP
|
+$243M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$260M |
| 2 |
Merck
MRK
|
+$260M |
| 3 |
S&P Global
SPGI
|
+$233M |
| 4 |
Occidental Petroleum
OXY
|
+$221M |
| 5 |
Walmart Inc
WMT
|
+$211M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.21% |
| 2 | Healthcare | 13.54% |
| 3 | Financials | 11.06% |
| 4 | Industrials | 10.41% |
| 5 | Consumer Discretionary | 7.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DOC
1901
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $382K | ﹤0.01% |
21,877
-106,598
| -83% | -$1.88M |
|
1902
Valley National Bancorp
VLY
$7.79B
| $381K | ﹤0.01% |
+36,561
| New | +$434K |
|
1903
Stem
STEM
$52.6M
| $380K | ﹤0.01% |
2,651
-38,815
| -94% | -$6.45M |
|
1904
Orthofix Medical
OFIX
$399M
| $379K | ﹤0.01% |
16,082
-5,732
| -26% | -$164K |
|
1905
PROG Holdings
PRG
$1.56B
| $379K | ﹤0.01% |
+22,999
| New | +$588K |
|
|
ACRE
1906
Ares Commercial Real Estate
ACRE
$262M
| $378K | ﹤0.01% |
30,874
-83,790
| -73% | -$1.22M |
|
1907
Saratoga Investment
SAR
$297M
| $378K | ﹤0.01% |
15,788
-36,109
| -70% | -$936K |
|
|
DOYU
1908
DouYu International Holdings
DOYU
$128M
| $376K | ﹤0.01% |
31,330
-56,016
| -64% | -$857K |
|
1909
Smart Sand
SND
$198M
| $376K | ﹤0.01% |
187,878
+98,627
| +111% | +$341K |
|
1910
Equitable Holdings
EQH
$13.4B
| $375K | ﹤0.01% |
+14,400
| New | +$417K |
|
1911
Tarsus Pharmaceuticals
TARS
$3.2B
| $375K | ﹤0.01% |
+25,719
| New | +$386K |
|
1912
Ivanhoe Electric
IE
$1.8B
| $374K | ﹤0.01% |
+43,000
| New | +$419K |
|
1913
Zumiez
ZUMZ
$312M
| $373K | ﹤0.01% |
+14,353
| New | +$483K |
|
1914
Sana Biotechnology
SANA
$1.13B
| $371K | ﹤0.01% |
57,749
-180,298
| -76% | -$1.15M |
|
|
NGMS
1915
DELISTED
NeoGames S.A. Ordinary Shares
NGMS
| $371K | ﹤0.01% |
27,692
-177,078
| -86% | -$2.41M |
|
|
KALV
1916
DELISTED
KalVista Pharmaceuticals
KALV
| $369K | ﹤0.01% |
+37,453
| New | +$413K |
|
|
PAYA
1917
DELISTED
Paya Holdings Inc. Class A Common Stock
PAYA
| $369K | ﹤0.01% |
+56,200
| New | +$317K |
|
1918
Capital Bancorp
CBNK
$596M
| $368K | ﹤0.01% |
16,949
-1,400
| -8% | -$31.2K |
|
1919
Hanmi Financial
HAFC
$926M
| $368K | ﹤0.01% |
+16,396
| New | +$380K |
|
|
IMOS
1920
ChipMOS TECHNOLOGIES
IMOS
$1.89B
| $368K | ﹤0.01% |
+14,745
| New | +$479K |
|
|
PPBI
1921
DELISTED
Pacific Premier Bancorp
PPBI
| $368K | ﹤0.01% |
+12,576
| New | +$402K |
|
1922
Evolus
EOLS
$580M
| $367K | ﹤0.01% |
31,621
+18,749
| +146% | +$221K |
|
1923
Lipocine
LPCN
$17M
| $367K | ﹤0.01% |
26,981
+5,800
| +27% | +$90.4K |
|
1924
CALL
State Street Industrial Select Sector SPDR ETF
XLI
$33.2B
| $367K | ﹤0.01% |
+4,200
| New | +$396K |
|
|
1925
PUT
State Street Industrial Select Sector SPDR ETF
XLI
$33.2B
| $367K | ﹤0.01% |
+4,200
| New | +$396K |
|
Similar funds
John Overdeck's Q2 2022 Portfolio in Review
As of Q2 2022, John Overdeck held 3,177 positions worth $30.3B, down 11% from $33.9B the previous quarter. Its ten largest holdings account for 8.2% of the portfolio.
John Overdeck deployed $2.33B of net new capital in Q2 2022, opening 628 new positions and adding to 764 existing holdings. Its largest new stake was Meta Platforms (Facebook): 1,541,482 shares worth $249M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Merck, an estimated $260M trimmed.
- John Overdeck's largest Q2 2022 buy was Meta Platforms (Facebook): 1,541,482 shares worth $249M.
- John Overdeck added most to Bank of America in Q2 2022, an estimated $249M increase.
- John Overdeck's biggest Q2 2022 reduction was Merck, cutting an estimated $260M.
- John Overdeck fully exited Tesla in Q2 2022, selling an estimated $260M.
- John Overdeck's ten largest holdings make up 8.2% of its $30.3B portfolio in Q2 2022.
- John Overdeck opened 628 new positions and closed 730 in Q2 2022.
- John Overdeck's portfolio value fell 11% quarter-over-quarter to $30.3B.
Based on Two Sigma Investments's 13F filing for Q2 2022, filed 15 Aug 2022.